Developed by the researcher and biologist Gaston Naessens in the 1970s, 714X is categorized as an immuno-modulator health product aiming to both support a weak immune system or to slow down an over-active one. It intends to restore the body's immune defenses without side effects.

714X is manufactured in Canada by the laboratory CERBE Inc. and has been exported to over 80 countries since 1990.

714X is a colorless liquid. Its therapeutic mode of action requires that it is introduced via injection into the lymphatic circulation (first treatment). In some cases, 714X can be introduced via the respiratory track using a nebulizer (secondary treatment).